A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Boehringer Ingelheim
Boehringer Ingelheim
Nanjing Sanhome Pharmaceutical, Co., Ltd.
University Health Network, Toronto
Coherus Oncology, Inc.
Turning Point Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Novita Pharmaceuticals, Inc.
Columbia University
Tvardi Therapeutics, Incorporated
Aptamer Sciences, Inc.
NantBioScience, Inc.
Xencor, Inc.
Pfizer
Second Affiliated Hospital of Guangzhou Medical University
Second Affiliated Hospital of Guangzhou Medical University
Pfizer
Celldex Therapeutics
Zhejiang University
Xencor, Inc.
Bristol-Myers Squibb
Quadriga Biosciences, Inc.
Xencor, Inc.
Pfizer
Gradalis, Inc.
Novartis
University of Chicago
Ivy Life Sciences, Co., Ltd
Masonic Cancer Center, University of Minnesota
Santa Maria Biotherapeutics
OrienGene Biotechnology Ltd.
Curis, Inc.
Memorial Sloan Kettering Cancer Center
University of Chicago
Duke University
National Institutes of Health Clinical Center (CC)
AstraZeneca